As of mid-2025, retatrutide remains in clinical trials and has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)
Use is not recommended while breastfeeding
Plaintiffs argue that the same physiological effect that improves blood sugar control, delayed digestion, may also contribute to severe medical events in vulnerable patients
MALDI-TOF: (M+H) + =4113.8, as shown inFigure 7
Do not use if the safety seal is damaged or missing
Hypoglycemia If youre taking Ozempic along with another medication to manage your blood sugar, such as sulfonylurea or insulin, its rare but possible to have hypoglycemia, which is when your blood sugar falls too low (below 70 mg/dL)